14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $19.00 $19.00 Tuesday, 6th Feb 2024 ICPT stock ended at $19.00. During the day the stock fluctuated 0% from a day low at $19.00 to a day high of $19.00.
90 days $19.00 $19.00
52 weeks $8.82 $21.86

Historical Intercept Pharmaceuticals prices

Date Open High Low Close Volume
Jan 21, 2016 $119.85 $123.00 $110.22 $112.21 745 900
Jan 20, 2016 $112.11 $123.20 $107.06 $120.11 643 100
Jan 19, 2016 $122.50 $123.92 $111.70 $114.29 676 300
Jan 15, 2016 $120.25 $122.74 $116.42 $121.70 1 193 100
Jan 14, 2016 $122.04 $126.87 $116.34 $124.24 554 700
Jan 13, 2016 $129.97 $131.99 $120.60 $121.04 508 800
Jan 12, 2016 $126.08 $134.00 $122.32 $129.06 695 500
Jan 11, 2016 $135.48 $138.46 $121.00 $123.60 551 500
Jan 08, 2016 $138.00 $141.17 $133.50 $134.43 333 400
Jan 07, 2016 $137.05 $141.67 $133.57 $135.74 443 600
Jan 06, 2016 $149.72 $151.01 $137.67 $139.67 407 400
Jan 05, 2016 $147.56 $152.60 $147.56 $151.44 325 000
Click to get the best stock tips daily for free!

About Intercept Pharmaceuticals

Intercept Pharmaceuticals Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination with ursodeoxycholic acid in adults. It is also developing Ocaliva for various indications, including nona... ICPT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT